Hematology
A section of Journal of Clinical Medicine (ISSN 2077-0383).
Section Information
Hematology is the subspecialty of internal medicine that deals with diseases of the blood, bone marrow, and lymphatic system. The main topics managed by hematologists include anemias, hematological malignancies (leukemias and lymphomas multiple myeloma) and other clonal disorders, transplantation of hematopoietic stem cells including cellular therapy, congenital and acquired diseases of hemostasis, coagulation, thrombotic diseases, blood banking, and transfusion medicine. The journal aims to provide information and updates on all aspects of clinical and laboratory hematology, from clinical trials to real-world clinical practice.
Subject areas:
- oncological and non-oncological hematological diseaseshematopoiesis
- disorders of leukocytes
- erythrocytes and platelets
- iron metabolism
- hemostaseology
- thrombotic and bleeding disorders
- immunology
- transfusion medicine
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Emerging Therapies and Strategies in Thalassemia: Toward a New Era in Management—2nd Edition (Deadline: 25 December 2024)
- Emerging Therapies for Multiple Myeloma (Deadline: 31 December 2024)
- Clinical Updates on Haemophilia (Deadline: 31 January 2025)
- Novel Therapeutic Strategies for Acute Myeloid Leukemia (Deadline: 15 February 2025)
- Advancements and Challenges in Treating Chronic Myeloproliferative Neoplasms (Deadline: 25 February 2025)
- Thrombosis: Latest Advances and Prospects (Deadline: 25 February 2025)
- New Diagnostic and Therapeutic Trends in Sepsis and Septic Shock (Deadline: 28 February 2025)
- Targeted Treatment of Hematological Malignancy (Deadline: 28 February 2025)
- Research Trends and Applications of Hematopoietic Stem Cell Transplantation (Deadline: 28 February 2025)
- Blood Disorders: Diagnosis, Management, and Future Opportunities (Deadline: 28 February 2025)
- Hemophilia: Current Trends and Future Directions (Deadline: 20 March 2025)
- Advances in Thrombosis and Haemostasis (Deadline: 30 March 2025)
- Thromboembolic Disease and Its Complications (Deadline: 31 March 2025)
- Acute Myeloid Leukemia: Latest Advances in the Diagnostics, Therapeutic Strategies and Clinical Management (Deadline: 25 April 2025)
- Myeloproliferative Neoplasms (MPN): Recent Advances, Current Practices and Future Perspectives (Deadline: 30 April 2025)
- Management, Diagnosis and Pathophysiology of Antiphospholipid Syndrome: Current Practice and Future Perspectives—2nd Edition (Deadline: 30 April 2025)
- Thromboembolic Disease and Antithrombotic Therapy (Deadline: 20 May 2025)
- Modern Blood Banking and Transfusion in Clinical Practice: Second Edition (Deadline: 25 May 2025)
- Blood Cancer: Current Status and Future Challenges in Acute Myeloid Leukemia (AML) (Deadline: 30 May 2025)
- Multiple Myeloma: Therapeutic and Management Strategies (Deadline: 30 May 2025)
- Hematologic Malignancies: Treatment Strategies and Future Challenges (Deadline: 26 June 2025)
- Haemophilia: Current Treatment and Clinical Outcomes, Challenges and Opportunities: 2nd Edition (Deadline: 31 July 2025)
- Clinical Advances in Treatment for Venous Thromboembolism (Deadline: 31 July 2025)
- New Insights in the Diagnosis, Treatment and Monitoring of Anemia, Inflammation and Infection (Deadline: 25 August 2025)
Topical Collection
Following topical collection within this section is currently open for submissions:
